BioAtla (BCAB) Stock Chart & Stock Price History $0.35 +0.02 (+6.18%) As of 02:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioAtla Stock Price Performance The BioAtla (BCAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 77.29%, with a year-to-date return of -40.46%. In the past month, the stock has decreased 7.37%, reflecting recent market activity. As of the latest close, BioAtla traded at $0.33 with a market cap of $19.37 million and volume of 273,097 shares. Receive BCAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioAtla and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.98%1 Month Performance-7.37%3 Month Performance-32.01%Year-To-Date Performance-40.46%1 Year Performance-77.29% BCAB Stock Chart for Tuesday, August, 5, 2025 BCAB Chart by TradingView BioAtla Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025$0.33$0.33+0.45%$0.35$0.33273,097 shs$19.37 million08/01/2025$0.36$0.33-8.10%$0.36$0.33492,189 shs$19.28 million07/31/2025$0.36$0.36-1.05%$0.37$0.35336,209 shs$20.98 million07/30/2025$0.35$0.36+4.40%$0.37$0.35759,965 shs$21.20 million07/29/2025$0.35$0.35-1.81%$0.38$0.33769,324 shs$20.31 million07/28/2025$0.35$0.35-0.23%$0.39$0.35452,874 shs$20.68 million07/25/2025$0.38$0.35-5.89%$0.38$0.351.59 million shs$20.73 million07/24/2025$0.40$0.38-5.70%$0.42$0.37660,172 shs$22.02 million07/23/2025$0.34$0.40+17.14%$0.40$0.35996,455 shs$23.36 million07/22/2025$0.34$0.34+1.58%$0.37$0.331.23 million shs$19.94 million Get the Latest News and Ratings for BCAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioAtla and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025$0.35$0.34-4.55%$0.37$0.331.29 million shs$19.63 million07/18/2025$0.37$0.35-5.02%$0.38$0.351.38 million shs$20.56 million07/17/2025$0.39$0.37-3.74%$0.41$0.371.08 million shs$21.65 million07/16/2025$0.39$0.39-2.26%$0.42$0.37900,547 shs$22.49 million07/15/2025$0.40$0.39-1.28%$0.42$0.39520,789 shs$23.01 million07/14/2025$0.38$0.40+4.04%$0.41$0.38572,876 shs$23.31 million07/11/2025$0.39$0.38-0.80%$0.39$0.38674,652 shs$22.40 million07/10/2025$0.39$0.39-0.31%$0.40$0.38618,511 shs$22.58 million07/09/2025$0.39$0.39-0.08%$0.42$0.39885,727 shs$22.66 million07/08/2025$0.39$0.39+0.54%$0.40$0.38485,663 shs$22.67 million07/07/2025$0.38$0.39+1.58%$0.40$0.38517,686 shs$22.55 million07/04/2025$0.38$0.38$0.39$0.361.33 million shs$22.20 million Related Companies CRVO Stock Price Chart MIST Stock Price Chart IPA Stock Price Chart CELU Stock Price Chart IMMX Stock Price Chart CABA Stock Price Chart PMVP Stock Price Chart MNOV Stock Price Chart GNTA Stock Price Chart IMA Stock Price Chart Receive BCAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioAtla and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BCAB) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioAtla, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioAtla With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
